| [1] |
Maddrey WC. Transplantation of the liver[M]. New York: Elsevier, 1988: 1-22.
|
| [2] |
Madrey WC, Sorrell MF. Transplantation of the Liver[M]. 2nd ed. Norwalk: Appleton and Lange, 1995: 225-245.
|
| [3] |
Margarit C, Martínez Ibañez V, Tormo R, et al. Maintenance immunosuppression without steroids in pediatric liver transplantation[J]. Transplant Proc,1989,21(1 Pt 2):2230-2231. http://cn.bing.com/academic/profile?id=2443370875&encoded=0&v=paper_preview&mkt=zh-cn
|
| [4] |
Yazawa H, Kato T, Nakada T, et al. Glucocorticoid hormone suppression of human neutrophil-mediated tumor cell cytostasis[J]. Int J Cancer,1999,81(1):74-80. doi: 10.1002/(ISSN)1097-0215
|
| [5] |
Ho WL, Wu CC, Yeh DC, et al. Roles of the glucocorticoid receptor in resectable hepatocellular carcinoma[J]. Surgery,2002,131(1):19-25. doi: 10.1067/msy.2002.118710
|
| [6] |
Miyagi S, Kawagishi N, Sekiguchi S, et al. The relationship between recurrences and immunosuppression on living donor liver transplantation for hepatocellular carcinoma[J]. Transplant Proc,2012,44(3):797-801. doi: 10.1016/j.transproceed.2012.01.012
|
| [7] |
Mazzaferro V, Rondinara GF, Rossi G, et al. Milan multicenter experience in liver transplantation for hepatocellular carcinoma[J]. Transplant Proc,1994,26(6):3557-3560. http://cn.bing.com/academic/profile?id=2404574882&encoded=0&v=paper_preview&mkt=zh-cn
|
| [8] |
Chen ZS, He F, Zeng FJ, et al. Early steroid withdrawal after liver transplantation for hepatocellular carcinoma[J]. World J Gastroenterol,2007,13(39):5273-5276. doi: 10.3748/wjg.v13.i39.5273
|
| [9] |
Xing T, Huang L, Yu Z, et al. Comparison of steroid-free immunosuppression and standard immunosuppression for liver transplant patients with hepatocellular carcinoma[J]. PLoS One,2013,8(8):e71251. doi: 10.1371/journal.pone.0071251
|
| [10] |
Stegall MD, Everson GT, Schroter G, et al. Prednisone withdrawal late after adult liver transplantation reduces diabetes, hypertension, and hypercholesterolemia without causing graft loss[J]. Hepatology,1997,25(1):173-177. doi: 10.1002/(ISSN)1527-3350
|
| [11] |
Segev DL, Sozio SM, Shin EJ, et al. Steroid avoidance in liver transplantation: meta-analysis and meta-regression of randomized trials[J]. Liver Transpl,2008,14(4):512-525. doi: 10.1002/(ISSN)1527-6473
|
| [12] |
Pekow JR, Bhan AK, Zheng H, et al. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis[J]. Cancer,2007,109(12):2490-2496. doi: 10.1002/(ISSN)1097-0142
|
| [13] |
Alsatie M, Kwo PY, Gingerich JR, et al. A multivariable model of clinical variables predicts advanced fibrosis in chronic hepatitis C[J]. J Clin Gastroenterol,2007,41(4):416-421. doi: 10.1097/01.mcg.0000225593.93577.64
|
| [14] |
Sgourakis G, Radtke A, Fouzas I, et al. Corticosteroid-free immunosuppression in liver transplantation: a meta-analysis and meta-regression of outcomes[J]. Transpl Int,2009,22(9):892-905. doi: 10.1111/tri.2009.22.issue-9
|
| [15] |
Kato T, Yoshida H, Sadfar K, et al. Steroid-free induction and preemptive antiviral therapy for liver transplant recipients with hepatitis C: a preliminary report from a prospective randomized study[J]. Transplant Proc,2005,37(2):1217-1219. doi: 10.1016/j.transproceed.2004.12.042
|
| [16] |
高学松,成军,甄真,等.核孔复合体相互作用蛋白(NPIP)对乙型肝炎病毒核心启动子转录活性的调节作用[J].世界华人消化杂志,2004,12(10):2488-2491. http://www.cnki.com.cn/Article/CJFDTotal-XXHB200410069.htm
Gao XS, Cheng J, Zhen Z, et al. Regulating effect of nuclear pore complex interaction proteins(NPIP) on transcriptional activity of core promoter of hepatitis B virus[J]. World Chin J Dig,2004,12(10):2488-2491. http://www.cnki.com.cn/Article/CJFDTotal-XXHB200410069.htm
|
| [17] |
Lupo L, Panzera P, TandoiF, et al. Basiliximab versus steroids in double therapy immunosuppression in liver transplantation: a prospective randomized clinical trial[J]. Transplantation,2008,86(7):925-931. doi: 10.1097/TP.0b013e318186b8a3
|
| [18] |
Liu CL, Fan ST, Lo CM, et al. Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage[J]. Liver Transpl,2004,10(6):728-733. doi: 10.1002/(ISSN)1527-6473
|
| [19] |
Figueras J, Prieto M, Bernardos A, et al. Daclizumab induction and maintenance steroid-free immunosuppression with mycophenolate mofetil and tacrolimus to prevent acute rejection of hepatic allografts[J]. Transpl Int,2006,19(8):641-648. doi: 10.1111/tri.2006.19.issue-8
|
| [20] |
Reggiani P, Arru M, Regazzi M, et al. A "steroid-free" tacrolimus and low-dose mycophenolate mofetil primary immunosuppression does not prevent early acute rejection after liver transplantation[J]. Transplant Proc,2005,37(4):1697-1699. doi: 10.1016/j.transproceed.2005.02.111
|
WeChat Subscription Account
Wechat Service Account
Supported by:
Beijing Renhe Information Technology Co. Ltd
DownLoad: